A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 60,448 shares of MIRM stock, worth $2.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,448
Holding current value
$2.7 Million
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$33.68 - $44.74 $2.04 Million - $2.7 Million
60,448 New
60,448 $2.36 Million
Q4 2023

Feb 13, 2024

SELL
$27.14 - $34.93 $272,811 - $351,116
-10,052 Reduced 14.63%
58,648 $1.73 Million
Q3 2023

Nov 14, 2023

BUY
$24.63 - $32.85 $1.41 Million - $1.88 Million
57,100 Added 492.24%
68,700 $2.17 Million
Q2 2023

Aug 11, 2023

SELL
$23.51 - $30.09 $47,020 - $60,180
-2,000 Reduced 14.71%
11,600 $300,000
Q1 2023

May 12, 2023

SELL
$19.19 - $24.1 $1.53 Million - $1.92 Million
-79,700 Reduced 85.42%
13,600 $327,000
Q4 2022

Feb 13, 2023

BUY
$17.59 - $23.83 $1.64 Million - $2.22 Million
93,300 New
93,300 $1.82 Million
Q2 2022

Aug 12, 2022

BUY
$18.42 - $27.5 $152,886 - $228,250
8,300 Added 25.0%
41,500 $808,000
Q1 2022

May 13, 2022

BUY
$15.5 - $23.93 $74,400 - $114,864
4,800 Added 16.9%
33,200 $731,000
Q4 2021

Feb 11, 2022

SELL
$13.05 - $19.35 $90,045 - $133,515
-6,900 Reduced 19.55%
28,400 $453,000
Q3 2021

Nov 12, 2021

SELL
$13.95 - $20.18 $196,695 - $284,538
-14,100 Reduced 28.54%
35,300 $703,000
Q2 2021

Aug 13, 2021

BUY
$15.84 - $20.6 $782,496 - $1.02 Million
49,400 New
49,400 $854,000
Q1 2021

May 13, 2021

SELL
$16.29 - $21.92 $698,841 - $940,368
-42,900 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$15.75 - $25.45 $675,675 - $1.09 Million
42,900 New
42,900 $749,000
Q3 2020

Nov 13, 2020

SELL
$18.4 - $26.59 $239,199 - $345,670
-13,000 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$11.51 - $20.97 $149,630 - $272,610
13,000 New
13,000 $253,000

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.64B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.